? ? Parkinson's Disease (PD) is a disabling neurodegenerative disease currently affecting more than 1.5 million people in the United States. While the etiology of PD is not completely known, it is believed that environmental factors play a major role in development of disease. Pesticide exposure is one of the few risk factors identified for PD by epidemiological studies. Research performed in the investigators' laboratories and others have determined that mitochondrial complex I and the vesicular monoamine transporter 2 (VMAT2) are targets of pesticides implicated in PD (e.g. rotenone, pyrethroids, and organochlorines) and that oxidative stress is a key mechanism of toxicity of these compounds. However, previous studies have focused primarily on a small number of pesticides. With this in mind, the investigators have developed a novel assay for rapidly screening pesticides for their ability to inhibit the binding of 3H-dihydrorotenone to complex I in isolated mitochondria and are developing rapid screens for identifying compounds that inhibit VMAT2 and cause oxidative damage. They have used these methods to screen a number of known complex I inhibitors and have identified the pesticide pyridaben as the most potent in generating oxidative stress and damaging cells. Because of the sheer number of pesticides and other environmental contaminants that may be involved in etiology of PD, it is important to develop a rapid screening paradigm to identify the toxicants most likely to damage the dopaminergic system. Here the investigators propose to build upon their experience with pesticides known to inhibit complex I to screen a number of pyrethroid and organochlorine pesticides for their ability to inhibit complex I and VMAT2, and generate oxidative damage. Data obtained from the in vitro screening phase will then be used to select the most likely candidates to damage the dopaminergic system and be tested for their ability to induce parkinsonism in mice. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54ES012068-03S1
Application #
6915360
Study Section
Special Emphasis Panel (ZES1-LKB-C (S1))
Program Officer
Kirshner, Annette G
Project Start
2002-08-26
Project End
2007-07-31
Budget Start
2005-06-01
Budget End
2005-07-31
Support Year
3
Fiscal Year
2005
Total Cost
$200,000
Indirect Cost
Name
Emory University
Department
Neurology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Richardson, Jason R; Taylor, Michele M; Shalat, Stuart L et al. (2015) Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. FASEB J 29:1960-72
Qi, Zhen; Miller, Gary W; Voit, Eberhard O (2009) Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals. Synapse 63:1133-42
Bayir, Hülya; Kapralov, Alexandr A; Jiang, Janfei et al. (2009) Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem 284:15951-69
Qi, Z; Miller, G W; Voit, E O (2008) A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia. Pharmacopsychiatry 41 Suppl 1:S89-98
Caudle, W Michael; Colebrooke, Rebecca E; Emson, Piers C et al. (2008) Altered vesicular dopamine storage in Parkinson's disease: a premature demise. Trends Neurosci 31:303-8
Voit, E O; Qi, Z; Miller, G W (2008) Steps of modeling complex biological systems. Pharmacopsychiatry 41 Suppl 1:S78-84
Hatcher, Jaime M; Pennell, Kurt D; Miller, Gary W (2008) Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 29:322-9
Greene, J G; Greenamyre, J T; Dingledine, R (2008) Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism. Neuroscience 152:198-207
Guillot, Thomas S; Shepherd, Kennie R; Richardson, Jason R et al. (2008) Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis. J Neurochem 106:2205-17
Evatt, Marian L; Delong, Mahlon R; Khazai, Natasha et al. (2008) Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65:1348-52

Showing the most recent 10 out of 50 publications